CymitQuimica logo
Trk receptor

Trk receptor

Trk receptor inhibitors target the Tropomyosin receptor kinases (Trk), a family of receptor tyrosine kinases that play a significant role in the development and function of the nervous system. Trk receptors are involved in neurotrophin signaling, which is essential for the survival, differentiation, and growth of neurons. Dysregulation of Trk signaling is associated with neurological disorders and certain cancers. At CymitQuimica, we offer Trk receptor inhibitors to support your research in neurobiology, oncology, and neurodegenerative diseases.

Found 70 products for "Trk receptor".

products per page.
  • TRK-IN-28
    Targetmol
    + Info

    TRK-IN-28

    CAS:
    TRK-IN-28 (compound 30f) functions as a TRK inhibitor, displaying potencies with IC 50 values of 0.55 nM for TRK WT, 25.1 nM for TRK G595R, and 5.4 nM for TRK G667C. Another TRK inhibitor, TRK-IN-2, exhibits antiproliferative effects with IC 50 values against multiple cell lines: 9.5 nM for Ba/F3-ETV6-TRKA WT, 3.7 nM for Ba/F3-ETV6-TRKB WT, 205.0 nM for Ba/F3-LMNA-TRK G595R, and 48.3 nM for Ba/F3-LMNA-TRKA G667C [1].
    Formula:C27H25F2N7
    Color and Shape:Solid
    Molecular weight:485.53

    Ref: TM-T87570

    10mg
    To inquire
    50mg
    To inquire
  • TRK-IN-26
    Targetmol
    + Info

    TRK-IN-26

    CAS:
    TRK-IN-26 (compound 12), a TRK inhibitor, holds potential for use in cancer research [1].
    Formula:C30H22F2N6O4
    Color and Shape:Solid
    Molecular weight:568.53

    Ref: TM-T87569

    10mg
    To inquire
    50mg
    To inquire
  • TrkA-IN-7
    Targetmol
    + Info

    TrkA-IN-7

    CAS:
    TrkA-IN-7 (Compound 4) is an inhibitor of tropomyosin receptor kinase A (TrkA), with a Kd value of 40 μM.
    Formula:C16H13N3O3
    Color and Shape:Solid
    Molecular weight:295.293

    Ref: TM-T204489

    10mg
    To inquire
    50mg
    To inquire
  • TrkA-IN-8
    Targetmol
    + Info

    TrkA-IN-8

    CAS:
    TrkA-IN-8 (Compound 2) is a TrkA inhibitor with a Kd value of 3.3 µM. RTKs-IN-1 demonstrates a concentration-dependent inhibitory effect on the proliferation of lung cancer cell lines and holds potential for research in non-small cell lung cancer.
    Formula:C20H16N4
    Color and Shape:Solid
    Molecular weight:312.3678

    Ref: TM-T205511

    10mg
    To inquire
    50mg
    To inquire
  • BNN-20
    Targetmol
    + Info

    BNN-20

    CAS:
    BNN-20 is a synthetic micro-neurotrophic factor that mimics Brain-Derived Neurotrophic Factor (BDNF) and exhibits region-specific neuroprotective and neurogenesis-promoting effects. It is applicable in research related to Parkinson's disease.
    Formula:C20H30O2
    Color and Shape:Solid
    Molecular weight:302.45

    Ref: TM-T201864

    10mg
    To inquire
    50mg
    To inquire
  • TrkA-IN-9
    Targetmol
    + Info

    TrkA-IN-9

    CAS:
    TrkA-IN-9 (VMD-928) is an orally active and selective inhibitor of tropomyosin receptor kinase A (TrkA). It disrupts downstream signaling pathways activated by nerve growth factor (NGF) binding to TrkA, thereby inhibiting cell proliferation and invasion, and promoting cancer cell death. TrkA-IN-9 shows potential for research in various cancers, including prostate cancer, thymic carcinoma, mesothelioma, head and neck squamous cell carcinoma, lung cancer, ovarian cancer, and hepatocellular carcinoma.
    Formula:C31H32N4O4
    Color and Shape:Solid
    Molecular weight:524.61

    Ref: TM-T206381

    10mg
    To inquire
    50mg
    To inquire
  • TrkC-IN-1
    Targetmol
    + Info

    TrkC-IN-1

    CAS:
    TrkC-IN-1 (Compound 6c) is an inhibitor of TrkC, with IC50 values of 3.3-7.1 and 7.3-10.2 μΜ for EBC-1 and HT-29 cells, respectively. This compound shows potential for research in the field of cancer therapeutics.
    Formula:C28H20BrN5O2
    Color and Shape:Solid
    Molecular weight:538.395

    Ref: TM-T206472

    10mg
    To inquire
    50mg
    To inquire
  • ONO-7579
    Targetmol
    + Info

    ONO-7579

    CAS:
    ONO-7579, an orally active TRKA inhibitor, effectively suppresses tumor growth by inhibiting TRKA phosphorylation. In KM12 colorectal cancer cells, it exhibits an EC 50 of 17.6 ng/g, indicating that a concentration of 17.6 ng per gram of tumor tissue reduces the activity of phosphorylated TRKA by 50%. This compound is utilized in cancer research.
    Formula:C24H18ClF3N6O4S
    Color and Shape:Solid
    Molecular weight:578.95

    Ref: TM-T200301

    25mg
    1,369.00€
    50mg
    1,783.00€
    100mg
    2,250.00€
  • NMS-P626
    Targetmol
    + Info

    NMS-P626

    CAS:
    NMS-P626 functions as an inhibitor targeting TRKA, TRKB, and TRKC, exhibiting IC 50 values of 8 nM, 7 nM, and 3 nM respectively. It effectively suppresses KM12 cell growth by inhibiting the phosphorylation of TPM3-TRKA and the subsequent downstream signaling, demonstrating an IC 50 of 19 nM specifically for KM12 cells. This compound is applicable in the study of colorectal cancer.
    Formula:C28H35F2N7O4S
    Color and Shape:Solid
    Molecular weight:603.68

    Ref: TM-T200149

    25mg
    2,178.00€
    50mg
    3,042.00€
    100mg
    3,870.00€
  • PF-06273340
    Targetmol
    + Info

    PF-06273340

    CAS:
    PF-06273340 是一种口服具有活力的、具有选择性的外周限制性Trk 泛抑制剂。
    Formula:C23H22ClN7O3
    Purity:98% - 98.00%
    Color and Shape:Solid
    Molecular weight:479.92

    Ref: TM-T19649

    1mg
    80.00€